203 related articles for article (PubMed ID: 35213727)
1. A preclinical model of patient-derived cerebrospinal fluid circulating tumor cells for experimental therapeutics in leptomeningeal disease from melanoma.
Law V; Chen Z; Vena F; Smalley I; Macaulay R; Evernden BR; Tran N; Pina Y; Puskas J; Caceres G; Bayle S; Johnson J; Liu JKC; Etame A; Vogelbaum M; Rodriguez P; Duckett D; Czerniecki B; Chen A; Smalley KSM; Forsyth PA
Neuro Oncol; 2022 Oct; 24(10):1673-1686. PubMed ID: 35213727
[TBL] [Abstract][Full Text] [Related]
2. Ex Vivo Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease.
Law V; Smalley I; Evernden BR; Baldwin M; Smalley KSM; Forsyth PA
J Vis Exp; 2024 Mar; (205):. PubMed ID: 38619274
[TBL] [Abstract][Full Text] [Related]
3. Tumor DNA in cerebral spinal fluid reflects clinical course in a patient with melanoma leptomeningeal brain metastases.
Li Y; Pan W; Connolly ID; Reddy S; Nagpal S; Quake S; Gephart MH
J Neurooncol; 2016 May; 128(1):93-100. PubMed ID: 26961773
[TBL] [Abstract][Full Text] [Related]
4. A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease.
Law V; Baldwin M; Ramamoorthi G; Kodumudi K; Tran N; Smalley I; Duckett D; Kalinski P; Czerniecki B; Smalley KSM; Forsyth PA
J Vis Exp; 2021 Jan; (167):. PubMed ID: 33586709
[TBL] [Abstract][Full Text] [Related]
5. Leptomeningeal Disease (LMD) in Patients with Melanoma Metastases.
Khaled ML; Tarhini AA; Forsyth PA; Smalley I; Piña Y
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980770
[TBL] [Abstract][Full Text] [Related]
6. Detection of Leptomeningeal Disease Using Cell-Free DNA From Cerebrospinal Fluid.
White MD; Klein RH; Shaw B; Kim A; Subramanian M; Mora JL; Giobbie-Hurder A; Nagabhushan D; Jain A; Singh M; Kuter BM; Nayyar N; Bertalan MS; Stocking JH; Markson SC; Lastrapes M; Alvarez-Breckenridge C; Cahill DP; Gydush G; Rhoades J; Rotem D; Adalsteinsson VA; Mahar M; Kaplan A; Oh K; Sullivan RJ; Gerstner E; Carter SL; Brastianos PK
JAMA Netw Open; 2021 Aug; 4(8):e2120040. PubMed ID: 34369989
[TBL] [Abstract][Full Text] [Related]
7. Leptomeningeal Metastasis: A Review of the Pathophysiology, Diagnostic Methodology, and Therapeutic Landscape.
Nguyen A; Nguyen A; Dada OT; Desai PD; Ricci JC; Godbole NB; Pierre K; Lucke-Wold B
Curr Oncol; 2023 Jun; 30(6):5906-5931. PubMed ID: 37366925
[TBL] [Abstract][Full Text] [Related]
8. Analysis of intrapatient heterogeneity of circulating tumor cells at the single-cell level in the cerebrospinal fluid of a patient with metastatic gastric cancer.
Cho JH; Sim MH; Kim SY; Kim K; Lee T; Lee J; Kang WK; Kim ST
J Cancer Res Ther; 2021; 17(4):1047-1051. PubMed ID: 34528562
[TBL] [Abstract][Full Text] [Related]
9. Leptomeningeal disease from melanoma-Poor prognosis despite new therapeutic modalities.
Chorti E; Kebir S; Ahmed MS; Keyvani K; Umutlu L; Kanaki T; Zaremba A; Reinboldt-Jockenhoefer F; Knispel S; Gratsias E; Roesch A; Ugurel S; Scheffler B; Schadendorf D; Livingstone E; Meier F; Glas M; Zimmer L
Eur J Cancer; 2021 May; 148():395-404. PubMed ID: 33789203
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of monitoring circulating tumor cells as a therapeutic biomarker in melanoma with BRAF mutation.
Kiniwa Y; Nakamura K; Mikoshiba A; Ashida A; Akiyama Y; Morimoto A; Okuyama R
BMC Cancer; 2021 Mar; 21(1):287. PubMed ID: 33731038
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of cerebrospinal fluid tumor cell count in leptomeningeal disease from solid tumors.
Barbour AB; Blouw B; Taylor LP; Graber JJ; McGranahan T; Blau M; Halasz LM; Lo SS; Tseng YD; Venur V; Yang JT
J Neurooncol; 2024 May; 167(3):509-514. PubMed ID: 38441840
[TBL] [Abstract][Full Text] [Related]
12. Advances in Diagnosis and Treatment for Leptomeningeal Disease in Melanoma.
Piña Y; Yadugiri S; Yeboa DN; Ferguson SD; Forsyth PA; Oliva ICG
Curr Oncol Rep; 2022 Jan; 24(1):43-54. PubMed ID: 35059999
[TBL] [Abstract][Full Text] [Related]
13. Spatial transcriptomics analysis identifies a unique tumor-promoting function of the meningeal stroma in melanoma leptomeningeal disease.
Alhaddad H; Ospina OE; Khaled ML; Ren Y; Forsyth P; Pina Y; Macaulay R; Law V; Tsai KY; Cress WD; Fridley B; Smalley I
bioRxiv; 2023 Dec; ():. PubMed ID: 38187574
[TBL] [Abstract][Full Text] [Related]
14. Ceritinib Enhances the Efficacy of Trametinib in
Verduzco D; Kuenzi BM; Kinose F; Sondak VK; Eroglu Z; Rix U; Smalley KSM
Mol Cancer Ther; 2018 Jan; 17(1):73-83. PubMed ID: 29133622
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal fluid circulating tumor cells as a quantifiable measurement of leptomeningeal metastases in patients with HER2 positive cancer.
Malani R; Fleisher M; Kumthekar P; Lin X; Omuro A; Groves MD; Lin NU; Melisko M; Lassman AB; Jeyapalan S; Seidman A; Skakodub A; Boire A; DeAngelis LM; Rosenblum M; Raizer J; Pentsova E
J Neurooncol; 2020 Jul; 148(3):599-606. PubMed ID: 32506369
[TBL] [Abstract][Full Text] [Related]
16. Surgical and anatomic factors predict development of leptomeningeal disease in patients with melanoma brain metastases.
Lowe SR; Wang CP; Brisco A; Whiting J; Arrington J; Ahmed K; Yu M; Robinson T; Oliver D; Etame A; Tran N; Beer Furlan A; Sahebjam S; Mokhtari S; Piña Y; Macaulay R; Forsyth P; Vogelbaum MA; Liu JKC
Neuro Oncol; 2022 Aug; 24(8):1307-1317. PubMed ID: 35092434
[TBL] [Abstract][Full Text] [Related]
17. Long-term control of leptomeningeal disease after radiation therapy and nivolumab in a metastatic melanoma patient.
Wu RC; Newman W; Patanowitz L; Branstetter BF; Amankulor N; Tarhini AA
Immunotherapy; 2020 Aug; 12(11):763-769. PubMed ID: 32571131
[No Abstract] [Full Text] [Related]
18. Proteomic Analysis of CSF from Patients with Leptomeningeal Melanoma Metastases Identifies Signatures Associated with Disease Progression and Therapeutic Resistance.
Smalley I; Law V; Wyatt C; Evernden B; Fang B; Koomen JM; Welsh EA; Macaulay RJB; Forsyth PA; Smalley KSM
Clin Cancer Res; 2020 May; 26(9):2163-2175. PubMed ID: 31924735
[TBL] [Abstract][Full Text] [Related]
19. mRNA expression and BRAF mutation in circulating melanoma cells isolated from peripheral blood with high molecular weight melanoma-associated antigen-specific monoclonal antibody beads.
Kitago M; Koyanagi K; Nakamura T; Goto Y; Faries M; O'Day SJ; Morton DL; Ferrone S; Hoon DS
Clin Chem; 2009 Apr; 55(4):757-64. PubMed ID: 19233913
[TBL] [Abstract][Full Text] [Related]
20. Leptomeningeal Metastases in Melanoma Patients: An Update on and Future Perspectives for Diagnosis and Treatment.
Steininger J; Gellrich FF; Engellandt K; Meinhardt M; Westphal D; Beissert S; Meier F; Glitza Oliva IC
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
